We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Onbevzi
Australian Public Assessment Report
Device/Product Name
Onbevzi
Active ingredients
Bevacizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04826-1-4
Submission Type
New biosimilar medicine
Decision
Approved